Form 4: Teladoc Health Executive Nikolaos P. Nanis Reports Stock Transactions
SEC Form 4 Filing
Nikolaos P. Nanis, Chief Technology Officer of Teladoc Health, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
Summary
- On July 1, 2024, Nikolaos P. Nanis, the Chief Technology Officer of Teladoc Health, had 1,233 restricted stock units vest, which converted to shares of TDOC common stock on a one-for-one basis.
- Following the vesting, Mr. Nanis sold 442 shares of common stock on July 2, 2024, at a price of $9.39 per share to cover tax withholding obligations.
- After these transactions, Mr. Nanis beneficially owns 73,226 shares of Teladoc Health common stock and 6,165 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a routine disclosure of stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, which can be informative for investors.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the sale of shares in the open market.
Key Dates
| Date | Description |
|---|---|
| 10/01/2022 | Reporting person was granted 14,793 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 07/01/2024 | 1,233 restricted stock units vested and converted to shares of TDOC common stock. |
| 07/02/2024 | 442 shares of common stock were sold at $9.39 per share to cover tax obligations. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.